Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Molecular imaging in drug development
2008 Standout
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma
2001
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Positron Emission Tomography Imaging of Cell Proliferation in Oncology
2003
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
2006
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
2001
Focus on lung cancer
2002
Head and neck cancer
2008 Standout
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy
2002
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Nasopharyngeal carcinoma
2019 Standout
Accuracy of FDG-PET to Diagnose Lung Cancer in a Region of Endemic Granulomatous Disease
2011
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data
2001
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Uptake Rates of 18F-Fluorodeoxyglucose and 11C-Choline in Lung Cancer and Pulmonary Tuberculosis
2003
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma
2008
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
2010
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
The Pursuit of Optimal Outcomes in Cancer Therapy in a New Age of Rationally Designed Target-Based Anticancer Agents
2000
Regulation of cancer cell metabolism
2011 Standout
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
2007 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Clinical role of positron emission tomography in oncology
2001
Nasopharyngeal carcinoma
2015 Standout
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis
2005
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004 Standout
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
HER1-Targeted 86Y-Panitumumab Possesses Superior Targeting Characteristics than 86Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
2011
Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review
2001
Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy
2002
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Positron emission tomography with CT in the evaluation of non‐small cell lung cancer in populations with a high prevalence of tuberculosis
2006
Early stage non-small-cell lung cancer: challenges in staging and adjuvant treatment: evidence-based staging
2010
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders
2001
Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography and Computed Tomography Scans
2004
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Methods for Staging Non-small Cell Lung Cancer
2013
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
2006 Standout
The fusion of anatomic and physiologic imaging in the management of patients with cancer
2001
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice
2007 StandoutNobel
Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18 FDG-hybrid PET fusion
2001
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
2002
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
2002
Silicosis
2012 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Positron Emission Tomography Scanning: Current and Future Applications
2002
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.
2001
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
2004
Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission Tomography
2005
Molecular Imaging with PET
2008
PET Scan in Lung Cancer: Current Recommendations and Innovation
2006
PET-based treatment planning in radiotherapy: a new standard?
2007
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
18F-FDG PET/CT Imaging In Oncology
2011
Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS)
2015
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.
2001
PET Scan in Lung Cancer: Current Recommendations and Innovation
2006
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy
2002
Works of Remge M. Pieterman being referenced
Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
2000
Quantitative imaging of 5-HT1A receptor binding in healthy volunteers with [18f]p-MPPF
2000
PET for the evaluation of pleural thickening observed on CT.
2004
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
2002